July 20, 2026

TransMedics Group, Inc. (TMDX) Stock Analysis: A Potential 54% Upside in Cutting-Edge Organ Care

TransMedics Group, Inc. (NASDAQ: TMDX), a pioneer in the healthcare sector specializing in medical devices, is making significant strides in transforming organ transplant therapy. With a market capitalization of $2.56..

Waystar Holding Corp. (WAY) Stock Analysis: Strong Buy Ratings and a Promising 50% Upside Potential

For investors seeking opportunities in the healthcare sector, Waystar Holding Corp. (WAY) presents an intriguing proposition. With its focus on developing innovative cloud-based software solutions for healthcare payments, Waystar stands..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating Growth Potential Amidst a 12.36% Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, operates as a leading pharmaceutical entity within the specialty and generic drug manufacturing industry. Headquartered in Hyderabad,..

BrightSpring Health Services (BTSG): Growth Potential in Healthcare with a 7.51% Upside

BrightSpring Health Services, Inc. (BTSG) stands out in the healthcare sector as a formidable player in the Health Information Services industry. With a market capitalization of $13.87 billion, BrightSpring is..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating Growth in the Medical Devices Sector

Integer Holdings Corporation (NYSE: ITGR) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $3.24 billion, this Plano, Texas-based..

Nuvalent Inc. (NUVL) Stock Analysis: Examining the Biotech’s Strategic Growth and Analyst Ratings

For investors keen on the biotechnology sector, Nuvalent, Inc. (NASDAQ: NUVL) presents a compelling case with its focus on developing innovative cancer therapies. The company, based in Cambridge, Massachusetts, operates..

Alkermes plc (ALKS) Stock Analysis: A Rising Star in the Biopharma Sector with 28.20% Revenue Growth

Alkermes plc (NASDAQ: ALKS), a prominent player in the biopharmaceutical industry, has been turning heads with its impressive financial performance and strategic focus on addressing unmet medical needs. As investors..

Qiagen N.V. (QGEN) Stock Analysis: Evaluating the 7.09% Upside Potential for Investors

For investors seeking opportunities in the healthcare sector, Qiagen N.V. (NYSE: QGEN) presents a compelling case with its robust presence in the diagnostics and research industry. Headquartered in Venlo, Netherlands,..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring a 28.77% Potential Upside for Investors

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a prominent player in the biotechnology sector, is capturing investor interest with its innovative approach to treating rare genetic diseases. With a current market capitalization..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Strong Analyst Support and 34% Potential Upside

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is capturing the attention of investors with its innovative approach to treating debilitating diseases through muscle activators and inhibitors...

Genmab A/S (GMAB) Stock Analysis: Investor Optimism with a 28.55% Potential Upside

Genmab A/S (GMAB) is a pivotal player in the biotechnology sector, commanding significant attention with its innovative antibody-based treatments for cancer and other serious diseases. Headquartered in Copenhagen, Denmark, Genmab..

Tenet Healthcare Corporation (THC) Stock Analysis: Strong Buy Ratings and 25% Upside Potential

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the healthcare sector, is capturing investor attention with its robust buy ratings and promising upside potential. As a diversified healthcare services..

Royalty Pharma plc (RPRX) Stock Analysis: Navigating Growth with an 11% Revenue Surge

Royalty Pharma plc (NASDAQ: RPRX), a notable player in the biotechnology sector, stands out with its unique business model as a buyer of biopharmaceutical royalties and a funder of innovation...

Baxter International Inc. (BAX) Stock Analysis: A Look at Its Market Position with a Cautious Investor Outlook

Baxter International Inc. (BAX), a stalwart in the healthcare sector, is known for its wide-ranging portfolio of medical products and therapies. Headquartered in Deerfield, Illinois, Baxter operates globally, catering to..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Exploring a 105% Potential Upside in RNA Therapeutics

Atrium Therapeutics, Inc. (NASDAQ: RNA), a promising player in the biotechnology sector, is capturing investor attention with its potential to revolutionize RNA therapeutics for cardiomyopathies. With a market capitalization of..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Growth Momentum But Analysts See Downside

Medpace Holdings, Inc. (NASDAQ: MEDP) is a standout player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $15.36 billion, Medpace is a..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Unveiling a 27.69% Potential Upside in the Healthcare Sector

Teva Pharmaceutical Industries (NYSE: TEVA), a prominent player in the healthcare sector, is capturing investor attention with its significant potential upside of 27.69%, as indicated by current analyst ratings. With..

Encompass Health Corporation (EHC) Stock Analysis: A 25% Upside Potential with Strong Buy Consensus

Investors seeking opportunities in the healthcare sector might find Encompass Health Corporation (NYSE: EHC) to be a compelling option. As a leading provider in the medical care facilities industry, Encompass..

Charles River Laboratories (CRL): Investor Outlook Reveals Promising Upside Amidst Sector Challenges

Charles River Laboratories International, Inc. (NYSE: CRL), a stalwart in the healthcare sector, particularly in diagnostics and research, commands a notable presence with its $10.81 billion market cap. Headquartered in..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A Healthcare Giant with 12.48% Potential Upside

IQVIA Holdings, Inc. (NYSE: IQV) stands as a formidable player in the healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization of $34.42 billion, IQVIA offers..

Search

Funds

July 20, 2026

Search

Funds

July 20, 2026

FTSE 100

Funds